DOXY 100 Drug Patent Profile
Which patents cover Doxy 100, and what generic alternatives are available?
Doxy 100 is a drug marketed by Fresenius Kabi Usa and is included in one NDA.
The generic ingredient in DOXY 100 is doxycycline hyclate. There is one drug master file entry for this compound. Seventy-seven suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Doxy 100
A generic version of DOXY 100 was approved as doxycycline hyclate by STRIDES PHARMA on March 29th, 1982.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DOXY 100?
- What are the global sales for DOXY 100?
- What is Average Wholesale Price for DOXY 100?
Summary for DOXY 100
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 52 |
| Patent Applications: | 2,651 |
| DailyMed Link: | DOXY 100 at DailyMed |
Pharmacology for DOXY 100
| Drug Class | Tetracycline-class Drug |
US Patents and Regulatory Information for DOXY 100
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | DOXY 100 | doxycycline hyclate | INJECTABLE;INJECTION | 062475-001 | Dec 9, 1983 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
